Last reviewed · How we verify

NCT03036033: T-SET

The SaeboGlove Evaluation Trial

Status unknown NA Last updated 30 January 2017
What this trial tests

NA trial testing SaeboGlove in Stroke in 12 participants. Status unknown.

Timeline
26 January 2017
Primary endpoint
25 May 2017
25 July 2017

Quick facts

Lead sponsorNHS Greater Glasgow and Clyde
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment12
Start date26 January 2017
Primary completion25 May 2017
Estimated completion25 July 2017
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

NHS Greater Glasgow and Clyde — full company profile →

Who can join

18 and older, any sex, with Stroke or Cerebral Vascular Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the safety, feasibility and usability of a SaeboGlove rehabilitation device in the treatment of patients who have reduced ability to open their hand due to weakness after an acute stroke.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. E-Poster Viewing
    · 2019 · cited 2×

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other NHS Greater Glasgow and Clyde trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03036033.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing